Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders

• প্রধান লেখক: O. A. Gromova (লেখক), I. Yu. Torshin (লেখক), A. N. Gromov (লেখক), O. V. Tikhonova (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: IRBIS LLC, 2024-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background. Renal-hepatic dysfunction, which often occurs in liver dysfunction, requires the use of effective and safe nephroprotective agents. Human placenta hydrolysates (HPH) are hepatoprotectors, but little is known about HPH nephroprotective properties and the molecular mechanisms of their impl...